Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

August
10
2017

Sensus Healthcare Offers Non-Surgical Option for Non-Melanoma Skin Cancer

CEO Joseph Sardano says skin cancer is often catching up with people earlier in life than it used to. Sensus Healthcare Inc. (SRTS) is marketing devices that offer some non-melanoma skin cancer (NMSC) patients an…

August
04
2017

Non-invasive procedure treats local residents’ non-melanoma skin cancer

Local residents are opting out of surgery, and are instead undergoing a non-invasive procedure for the treatment of non-melanoma skin cancers. The SRT-100, which met standards set by the U.S. Food and Drug Administration, is…

August
03
2017

Sensus Healthcare Reports Record Second Quarter Financial Results

Revenue growth of 39% marks seventh consecutive quarter of double-digit year-over-year gains Conference call begins at 4:30 Eastern time today BOCA RATON, Fla., Aug. 3, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device…

July
31
2017

Offer Your Patients Non-Surgical Keloid Treatment

If you have patients with keloid scars on their chest, back, shoulders, earlobes, or face, you know and understand just how frustrating, annoying, and embarrassing those keloid scars can be. They’re itchy and sometimes quite…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy